If your patients are suffering from mental health challenges, the last thing they want is to go through a lengthy trial and error process with multiple medications. The process can be frustrating and leave patients feeling worse, not better. Fortunately, the GeneSight Psychotropic test can provide information that helps you choose medications that can lead your patient to relief. By examining how your patient’s DNA responds to specific medications such as antidepressants, this simple, painless test lets you know which medications may not work for your patient, so you can get more of them into remission faster. That’s the power and simplicity of the GeneSight test.
Kroger Prescription Plans is focused on improving the health and wellness of all our members. As part of your plan benefits, you are eligible to receive the GeneSight Psychotropic at no cost.
Become a provider of the GeneSight test
Largest Mental Health Pharmacogenomic Clinical Study Ever Proves GeneSight® Psychotropic Test Efficacy
as Published in the Journal of Psychiatric Research
Collect a DNA sample by painlessly swabbing the inside of your cheek
The sample is sent to our lab for analysis
Just 36 hours later, your patient’s report is available for review.
Guided by insights from your report, you can avoid being undermined by genetic variability.
See what happens when the GeneSight® test becomes part of a clinician’s practice.
Learn more about pharmacogenomics
A Medscape CME Course Available Now
The ABCs of Pharmacogenomics in Clinical Practice is designed to increase clinicians’ knowledge and competence on the emerging role of pharmacogenomics testing in psychiatric care. The faculty, Roger S. McIntyre, MD and Sagar Parikh, MD, will interpret current information, including the latest clinical data, and share their experience with available tests, to build confidence in decision making and competence in optimizing the use of combinatorial pharmacogenomics to improve patient outcomes.